Orient Pharma Co Ltd (4166)

Currency in TWD
33.85
-1.15(-3.29%)
Delayed Data·
4166 Scorecard
Full Analysis
Stock has taken a big hit over the last week
Unusual trading volume
4166 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
33.1035.50
52 wk Range
24.8550.70
Key Statistics
Bid/Ask
18.01 / 18.69
Prev. Close
35.2
Open
35.5
Day's Range
33.1-35.5
52 wk Range
24.85-50.7
Volume
250.43K
Average Volume (3m)
80.87K
1-Year Change
26.07%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4166 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Orient Pharma Co Ltd Company Profile

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.

Employees
173
Market
Taiwan

Compare 4166 to Peers and Sector

Metrics to compare
4166
Peers
Sector
Relationship
P/E Ratio
62.9x−14.4x−0.5x
PEG Ratio
0.630.100.00
Price/Book
4.1x2.1x2.6x
Price / LTM Sales
6.0x5.4x3.3x
Upside (Analyst Target)
-0.0%42.9%
Fair Value Upside
Unlock−3.0%6.2%Unlock

Earnings

Latest Release
Jun 30, 2025
EPS / Forecast
0.23 / --
Revenue / Forecast
316.90M / --
EPS Revisions
Last 90 days

4166 Income Statement

FAQ

What Stock Exchange Does Orient Pharma Trade On?

Orient Pharma is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Orient Pharma?

The stock symbol for Orient Pharma is "4166."

What Is the Orient Pharma Market Cap?

As of today, Orient Pharma market cap is 7.55B.

What Is Orient Pharma's Earnings Per Share (TTM)?

The Orient Pharma EPS (TTM) is 0.54.

From a Technical Analysis Perspective, Is 4166 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Orient Pharma Stock Split?

Orient Pharma has split 2 times.

How Many Employees Does Orient Pharma Have?

Orient Pharma has 173 employees.

What is the current trading status of Orient Pharma (4166)?

As of 12 Aug 2025, Orient Pharma (4166) is trading at a price of 33.85, with a previous close of 35.20. The stock has fluctuated within a day range of 33.10 to 35.50, while its 52-week range spans from 24.85 to 50.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.